Similar Papers

Paper Title
Journal
Date
Author
Commentary: Another win for immunotherapy
Alison Halpern Mungo ... Elizabeth A David
The Journal of Thoracic and Cardiovascular Surgery | VOL. 165
Alison Halpern Mungo, et. al.Alison Halpern Mungo ... Elizabeth A David
09 Sep 2022
Nit-Picking around second line inEGFRwt NSCLC: just an academic effort
L Landi ... F Cappuzzo
Annals of Oncology | VOL. 26
L Landi, et. al.L Landi ... F Cappuzzo
01 Mar 2015
EGFR Mutations in Lung Cancer: Different Frequencies for Different Folks
Adi F Gazdar
Journal of Thoracic Oncology | VOL. 9
Adi F GazdarAdi F Gazdar
01 Feb 2014
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
L.E Hendriks ... M Reck
Annals of Oncology | VOL. 34
L.E Hendriks, et. al.L.E Hendriks ... M Reck
23 Jan 2023
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
89P Spatial analysis using MultiOmyx hyperplex assay reveals high prevalence of mature tertiary lymphoid structure (TLS) and PDL1 expression in the MSI-high colorectal carcinoma (CRC)
Q Au ... V Chizhevsky
Annals of Oncology | VOL. 35
Q Au, et. al.Q Au ... V Chizhevsky
01 Dec 2024
276MO Epidemiology, treatment (tx) patterns, and clinical outcomes of patients (pts) with locally advanced or metastatic urothelial cancer (la/mUC) in Taiwan: A retrospective cohort study
C-T Wu ... L-N Chien
Annals of Oncology | VOL. 35
C-T Wu, et. al.C-T Wu ... L-N Chien
01 Dec 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.